These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6892371)

  • 1. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in swine with open thorax].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6892371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
    Coma-Canella I
    Ter Arkh; 1982; 54(11):104-5. PubMed ID: 6130619
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
    Dahlström U; Karlsson E
    Acta Med Scand; 1982; 212(3):125-30. PubMed ID: 6128867
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
    Reiz S; Friedman A; Häggmark S
    Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
    Kirlin PC; Romson JL; Pitt B; Lucchesi B
    Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
    Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
    Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R
    Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
    Kulling P
    Acta Med Scand Suppl; 1982; 659():191-9. PubMed ID: 6127889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulatory effects of prenalterol (selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
    Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Lu Quo Ging ; Guazzi M
    Cardiologia; 1982; 27(1):99-101. PubMed ID: 6892381
    [No Abstract]   [Full Text] [Related]  

  • 13. Ventilatory and haemodynamic effects of beta 1-selective and beta 2-selective stimulation in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Respir Dis Suppl; 1984; 135():147-50. PubMed ID: 6329801
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenalterol in symptomatic sinus node dysfunction.
    Feleke E; Rydén L; Smedgård P; Westerling S
    Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog.
    Strosberg AM; Montgomery W
    Proc West Pharmacol Soc; 1981; 24():83-7. PubMed ID: 7255492
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The effects of practolol in the early stages of experimental myocardial infarction.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1974 Sep; 52(1):124P. PubMed ID: 4451779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrophysiologic effects of prenalterol On sinus function in coronary disease patients].
    Bolognesi R; Cucchini F; Giacometti P; Sartori M; Zeppellini R; Javernaro A; Potenza D
    Cardiologia; 1982; 27(2):219-22. PubMed ID: 6927435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prenalterol (Hyprenan). A new cardiotonic agent].
    Pelle H; Svendsen TL; Kampmann JP
    Ugeskr Laeger; 1982 Dec; 144(49):3688-90. PubMed ID: 6133384
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrophysiological effects of practolol in patients with acute myocardial infarct].
    Rosettani E; Mangiardi L; Orzan F; Bonamini R; Casaccia M; Brusca A
    Boll Soc Ital Cardiol; 1974; 19(7):671-8. PubMed ID: 4464965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
    Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
    Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.